Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Medtronic
Federal Trade Commission
Cipla
Baxter
Accenture
Harvard Business School
Covington
Fish and Richardson
Dow

Generated: August 19, 2017

DrugPatentWatch Database Preview

SOMOPHYLLIN-CRT Drug Profile

« Back to Dashboard

Which patents cover Somophyllin-crt, and when can generic versions of Somophyllin-crt launch?

Somophyllin-crt is a drug marketed by Graham Dm and is included in five NDAs.

The generic ingredient in SOMOPHYLLIN-CRT is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: SOMOPHYLLIN-CRT

Patents:0
Applicants:1
NDAs:5
Bulk Api Vendors: see list85
Clinical Trials: see list162
Patent Applications: see list9,690
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SOMOPHYLLIN-CRT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm
SOMOPHYLLIN-CRT
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087763-001Feb 27, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Graham Dm
SOMOPHYLLIN-CRT
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087193-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Graham Dm
SOMOPHYLLIN-CRT
theophylline
CAPSULE, EXTENDED RELEASE;ORAL088382-001Feb 27, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Graham Dm
SOMOPHYLLIN-CRT
theophylline
CAPSULE, EXTENDED RELEASE;ORAL088383-001Feb 27, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Graham Dm
SOMOPHYLLIN-CRT
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087194-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Deloitte
Baxter
McKesson
Dow
Argus Health
Farmers Insurance
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot